Skip to main content
. 2006 Jan 27;394(Pt 1):19–26. doi: 10.1042/BJ20050941

Figure 5. Cyclopamine does not influence the PTCH1 inhibition of GLI1 activity.

Figure 5

NIH-3T3 cells were transfected with the 12GLI RETKO luciferase construct, Renilla luciferase transfection control and expression constructs as indicated, and treated with or without the SMO antagonist cyclopamine at 10 μM concentration. Note that this treatment has no appreciable effects on the PTCH1 inhibition of GLI1 activity.